Suppr超能文献

乳酸菌和酵母菌菌株联合培养后制剂的抗菌活性。

Antimicrobial activity of preparations after combined cultivation of lactic acid bacteria and yeast strains.

作者信息

Balabekyan Ts R, Karapetyan K J, Khachatryan T V, Khachatryan G E, Tatikyan S Sh

机构信息

Scientific and Production Center "Armbiotechnology", NAS, Yerevan, Republic of Armenia.

Candle Synchrotron Research Institute, Yerevan, Republic of Armenia.

出版信息

J Anim Physiol Anim Nutr (Berl). 2018 Aug;102(4):933-938. doi: 10.1111/jpn.12891. Epub 2018 Mar 30.

Abstract

Use of antimicrobials in both human and animal populations over the past several decades has led to the emergence of multidrug-resistant bacteria populations that are resistant to many commercially available drugs. For example, acquired resistance to first-line antimicrobial agents increasingly complicates the management of extra-intestinal infections due to Escherichia coli, which are a major source of illness and death. The continued development of new classes of natural antimicrobial agents, possessing antibacterial activity, has become of increasing importance for medicine and veterinary. So, selection of lactic acid bacteria and yeast strains for their combined cultivation with the aim of increasing of the activity is topical. It was shown that during combined cultivation of the lactic acid bacteria with probiotic properties and yeast strains, antimicrobial activity depends on the genus and species to which the strain of lactic acid bacteria and yeast belongs. They inhibited the growth of multidrug-resistant bacteria with better efficiency. Increasing of the antimicrobial activity can be explained by the synergetic effect of products of cultures metabolism and by interaction between lactic acid bacteria cells with the cell wall of yeasts. Our data showed perspectives of combined cultivation of yeast and lactic acid bacteria for creation of a new class of antimicrobial preparations with high antibacterial activity and broad spectrum of action. Preparation can be recommended for treatment of animals.

摘要

在过去几十年中,人类和动物群体中抗菌药物的使用导致了对许多市售药物具有抗性的多重耐药细菌群体的出现。例如,对一线抗菌药物获得性耐药使得因大肠杆菌引起的肠外感染的治疗日益复杂,而大肠杆菌是疾病和死亡的主要来源。持续开发具有抗菌活性的新型天然抗菌剂对医学和兽医学变得越来越重要。因此,选择乳酸菌和酵母菌株进行联合培养以提高活性是热门话题。结果表明,在具有益生菌特性的乳酸菌与酵母菌株联合培养过程中,抗菌活性取决于乳酸菌和酵母菌株所属的属和种。它们能更有效地抑制多重耐药细菌的生长。抗菌活性的提高可以通过培养物代谢产物的协同作用以及乳酸菌细胞与酵母细胞壁之间的相互作用来解释。我们的数据显示了酵母和乳酸菌联合培养以创建一类具有高抗菌活性和广谱作用的新型抗菌制剂的前景。该制剂可推荐用于动物治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验